Vaccines, blood, antisera, toxins and cultures in   Netherlands

Exports In 2022, Netherlands exported $13.8B in Vaccines, blood, antisera, toxins and cultures, making it the 6th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in Netherlands. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Netherlands are: Germany ($3.15B), United States ($2.25B), France ($1.54B), Italy ($987M), and Spain ($683M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Netherlands between 2021 and 2022 were United States ($543M), Switzerland ($117M), and Ethiopia ($91.7M).

Imports In 2022, Netherlands imported $15.8B in Vaccines, blood, antisera, toxins and cultures, becoming the 6th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Netherlands. Netherlands imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($4.65B), United States ($3.74B), Italy ($2.62B), Ireland ($2.04B), and Belgium ($645M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Netherlands between 2021 and 2022 were Germany ($3.19B), Ireland ($1.98B), and United States ($754M).